The Lausanne Institutional Biobank: A new resource to catalyse research in personalised medicine and pharmaceutical sciences
Breakthrough technologies which now enable the sequencing of individual genomes will irreversibly modify the way diseases are diagnosed, predicted, prevented and treated. For these technologies to reach their full potential requires, upstream, access to high-quality biomedical data and samples fro...
Main Authors: | Vincent Mooser, Christine Currat |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2014-11-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/1950 |
Similar Items
-
High participation rate among 25 721 patients with broad age range in a hospital-based research project involving whole-genome sequencing – the Lausanne Institutional Biobank
by: Murielle Bochud, et al.
Published: (2017-10-01) -
Identification and molecular characterisation of Lausanne Institutional Biobank participants with familial hypercholesterolaemia – a proof-of-concept study
by: Fabienne Maurer, et al.
Published: (2016-07-01) -
The Information Technology Infrastructure for the Translational Genomics Core and the Partners Biobank at Partners Personalized Medicine
by: Natalie Boutin, et al.
Published: (2016-01-01) -
Biobanks : patents or open science/
by: De Robbio, Antonella
Published: (2013) -
BIOBANKS ARE AN ESSENTIAL TOOL FOR TRANSPLANTATION. HISTORY, CURRENT STATE, PERSPECTIVES
by: O. N. Reznik, et al.
Published: (2017-01-01)